Arcus Biosciences, Inc. (RCUS) Cash Flow Annual - Discounting Cash Flows
RCUS
Arcus Biosciences, Inc.
RCUS (NYSE)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Report Filing: 2025-10-28 2025-02-25 2024-02-21 2023-02-28 2022-02-23 2021-02-25 2020-03-05 2019-03-05 2017-12-31 2016-12-31
Net Income/Starting Line -341 -283 -307 -267 52.83 -122.9 -84.71 -49.59 -53.08 -17.97
Cash From Operating Activities -462 -170 -306 438 -256.2 111.2 -73.46 -43 -25.06 -12.94
Depreciation and Amortization 10 10 8 14 3.84 4.19 3.58 3.66 2.61 1.31
Deferred Income Tax 0 0 0 0 4.77 0 0 -2.1 0.416 -0.09
Stock Based Compensation 47 76 73 0 55 22 8.98 3.87 0.495 0.09
Other Non-Cash Items 9 5 -9 68 3.47 -0.046 -1.44 -0.177 -0.098 0.09
Changes in Working Capital -187 22 -71 623 -375.6 208.1 0.125 1.33 24.6 3.62
Accounts Receivable 5 28 15 704 -17.05 -0.917 -0.049 -0.058 0.38 0
Inventory 0 0 0 0 14.09 21.32 0 0 0 0
Accounts Payable 29 3 -1 8 -4.77 9.27 1.73 -0.069 -0.267 3.57
Deferred Revenue -221 -9 -85 -89 -367.9 178.4 -1.55 1.4 24.86 0.053
Other Working Capital 0 0 0 0 0 0 0 0.058 -0.38 0
Cash From Investing Activities 299 -84 194 -413 -3.87 -434.4 59.21 -113.4 -49.07 -38.86
Investments in Property Plant and Equipment -2 -6 -24 -6 -26.08 -3.06 -1.93 -3.74 -5.51 -4.1
Payments for Acquisitions 0 0 0 0 -22 431 0 0 0 -1
Purchases of Securities -851 -1,043 -788 -1,241 -718.9 -739.7 -247.8 -261.6 -96.83 -33.76
Sales and Maturities of Investments 1,152 965 1,006 837 741.1 308.3 308.9 151.9 53.27 1
Other Investing Activities 0 0 0 -3 22 -431 0 -109.7 -43.56 -1
Cash From Financing Activities 200 277 33 33 237.3 438.7 1.12 129.1 107.4 70.1
Debt Repayment 49 47 0 10 5 0 0 0 0 0
Common Stock Issued 153 228 25 23 220 434 0 125.1 0.892 70.1
Common Stock Repurchased 0 0 0 0 -0.006 -0.054 -0.094 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities -2 2 8 0 12.34 4.67 1.22 3.96 107.4 70.1
Effect of Forex Changes on Cash 0 0 0 0.086 0 0 0 0 0 0
Net Change in Cash 88 23 -79 58.09 -22.7 115.5 -13.13 -27.36 33.27 18.3
Cash at Beginning of Period 153 130 209 147.9 173.6 58.14 71.27 98.43 65.16 46.87
Cash at End of Period 241 153 130 206 150.9 173.6 58.14 71.06 98.43 65.16
Free Cash Flow -464 -176 -330 432 -282.2 108.1 -75.39 -46.74 -30.57 -17.04
Operating Cash Flow -462 -170 -306 438 -256.2 111.2 -73.46 -43 -25.06 -12.94
Capital Expenditure -2 -6 -24 -6 -26.08 -3.06 -1.93 -3.74 -5.51 -4.1
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program